Sansure Biotech (SHSE:688289) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 29, 2026)


SHSE:688289 Sansure Biotech Inc SHSE:688289
67 GF Score
Price ¥14.70
GF Value ¥20.52
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Sansure Biotech Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Sansure Biotech's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

SHSE:688289 vs ISRG, BDX, MDLN: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Instruments & Supplies subindustry, Sansure Biotech's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sansure Biotech Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sansure Biotech's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Sansure Biotech's Margin of Safety % (DCF FCF Based) falls into.


SHSE:688289
67GF Score
Sansure Biotech Inc SHSE:688289
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sansure Biotech (SHSE:688289) Overvalued in 2026?

Based on GuruFocus' analysis, Sansure Biotech stock appears to be undervalued. The current stock price of ¥14.70 is trading 28.4% below its estimated GF Value™ of ¥20.52. GuruFocus considers Sansure Biotech to be Modestly Undervalued.

Key valuation signals for SHSE:688289:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ¥20.52 vs. price of ¥14.70 (28.4% below fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sansure Biotech Business Description

Address No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205
Sansure Biotech Inc is engaged in the Research, development, production, and sales of diagnostic reagents and instruments.
67GF Score

Get the complete analysis for SHSE:688289

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.70
Price
¥20.52
GF Value